Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral fosfomycin after carbapenems as de-escalating therapy in complicated urinary tract infections
TCTR20250608001Phase 4Completed
- Sponsor
- No
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fosfomycin in complicated urinary tract infection (cUTI) (2 arms), sponsored by No. Started Aug 2023; status: completed.
02
Drugs
fosfomycin
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on TCTR20250608001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250608001.